Implementing HIV Pre-Exposure Prophylaxis at Federal Healthcare Facilities


This session provides an overview of HIV Pre-Exposure Prophylaxis (PrEP), including how to identify potential PrEP candidates, how to initiate medication, and how to monitor patients while on therapy. Additionally, this session explores the role pharmacists can play in expanding access to PrEP in their facilities and examines the clinic model currently in use at Phoenix Indian Medical Center.    

Pharmacist Learning Objectives

At the completion of this activity, participants will be able to:

  1. Discuss which patients may benefit from PrEP to prevent HIV acquisition.
  2. Describe current practice standards to suggest screening and management strategies for patients taking PrEP.
  3. Outline a patient-specific pharmacologic plan and monitoring strategy for patients taking PrEP.



Technician Learning Objectives



Janet Cifuentes, PharmD, BCPS, AAHIVP
Clinical Pharmacist
Phoenix Indian Medical Center
Learning Level: Level 2
Track: Clinical Patient Care
Session Time Slot(s): 
Wednesday, October 30
8:00 AM - 9:00 AM
Hilton Anatole Dallas - Coronado D
ACPE Pharmacist: 0202-0000-19-184-L01-P
CEUs Pharmacist: .1
Activity Type: